(Q45884323)

17 December 2017

title

Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors (English)

1 reference

17 December 2017

1 reference

Florian Kreppel

1

1 reference

17 December 2017

Judith Gackowski

series ordinal

2

1 reference

17 December 2017

Erika Schmidt

series ordinal

3

1 reference

17 December 2017

Stefan Kochanek

series ordinal

4

1 reference

17 December 2017

language of work or name

1 reference

1 July 2005

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

107-117

1 reference

17 December 2017

Targeting of high-capacity adenoviral vectors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Targeting of adenoviral vectors through a bispecific single-chain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Antibody-mediated targeting of an adenovirus vector modified to contain a synthetic immunoglobulin g-binding domain in the capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-defici

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Targeting adenoviral vectors using heterofunctional polyethylene glycol FGF2 conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Transferrin/transferrin receptor-mediated drug delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

A DNA-based method to assay total and infectious particle contents and helper virus contamination in high-capacity adenoviral vector preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

7 January 2021

Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

7 January 2021

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

7 January 2021

Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.03.006

7 January 2021

10.1016/J.YMTHE.2005.03.006

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017